Europe Biopharmaceutical Third-Party Logistics Market Size & Outlook
Global Market
Related Markets
Europe biopharmaceutical third-party logistics market highlights
- The Europe biopharmaceutical third-party logistics market generated a revenue of USD 39,722.6 million in 2025.
- The market is expected to grow at a CAGR of 5.57% from 2026 to 2033.
- In terms of segment, non-cold chain logistics was the largest revenue generating supplychain in 2025.
- Cold Chain Logistics is the most lucrative supplychain segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 39,722.6 million |
| Market revenue in 2033 | USD 60,845.6 million |
| Growth rate | 5.57% (CAGR from 2026 to 2033) |
| Largest segment | Non-cold chain logistics |
| Fastest growing segment | Cold Chain Logistics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Non-cold Chain Logistics, Cold Chain Logistics |
| Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.1% of the global biopharmaceutical third-party logistics market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 48,503.5 million by 2033.
Europe biopharmaceutical third party logistics market accounted for 24.5% of the global market in 2020. The major countries in the European region include the UK, Germany, France, Italy, and Spain.
These five countries accounted for a combined share of 91.5% in 2020 in the European biopharmaceutical third party logistics market. High biopharmaceutical R&D investments coupled with robust logistic performance index in the region can be attributed to the significant market share.
No credit card required*
Publish Date: Aug 05, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biopharmaceutical Third-Party Logistics Market Scope
Biopharmaceutical Third-Party Logistics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DHL Group | View profile | 594,396 | Platz der Deutschen Post, Bonn, NW, Germany, 53250 | www.dpdhl.com |
| United Parcel Service Inc Class B | View profile | 500,000 | 55 Glenlake Parkway, N.E. Atlanta, Atlanta, GA, United States, 30328 | www.ups.com |
| Kerry Logistics Network Ltd | View profile | 33,100 | 55 Wing Kei Road, 16th Floor, Kerry Cargo Centre, New Territories, Kwai Chung, Hong Kong, Hong Kong, | www.kln.com |
| Kuehne + Nagel International AG | View profile | 93,064 | Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 | www.kuehne-nagel.com |
| AmerisourceBergen Drug Corporation | View profile | 11-50 | Kelayres, Pennsylvania, United States, North America | www.amerisourcebergendrug.com |
| SF Express | View profile | 10001+ | Shenzhen, Guangdong, China, Asia | www.sf-cityrush.com |
| DB Schenker | View profile | 10001+ | Essen, Nordrhein-Westfalen, Germany, Europe | www.dbschenker.com/global |
| Agility | View profile | 10001+ | Singapore, Central Region, Singapore, Asia | www.agility.com |
Europe Biopharmaceutical Third-party Logistics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biopharmaceutical Third-party Logistics Market Outlook will help companies and investors design strategic landscapes.
Non-Cold Chain Logistics was the largest segment with a revenue share of 82.57% in 2025.
Horizon Databook has segmented the Europe biopharmaceutical third-party logistics market based on non-cold chain logistics, cold chain logistics covering the revenue growth of each sub-segment from 2021 to 2033.
Europe biopharmaceutical third party logistics market accounted for 24.5% of the global market in 2020. The major countries in the European region include the UK, Germany, France, Italy, and Spain.
These five countries accounted for a combined share of 91.5% in 2020 in the European biopharmaceutical third party logistics market. High biopharmaceutical R&D investments coupled with robust logistic performance index in the region can be attributed to the significant market share.
- Europe Biopharmaceutical Third-Party Logistics Market SupplyChain Outlook (Revenue, USD Million , 2021-2033)
- Cold Chain Logistics
- Non-cold Chain Logistics
- Europe Biopharmaceutical Third-Party Logistics Market Services Type Outlook (Revenue, USD Million , 2021-2033)
- Transportation
- Warehousing and Storage
- Other Services
Reasons to subscribe to Biopharmaceutical Third-party Logistics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biopharmaceutical Third-party Logistics Market Outlook databook
- Our clientele includes a mix of Biopharmaceutical Third-party Logistics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Biopharmaceutical Third-party Logistics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Biopharmaceutical Third-party Logistics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Biopharmaceutical Third-Party Logistics Market, 2021-2033 (US$M)
Europe SupplyChain - Biopharmaceutical Third-party Logistics Market Statistics, 2025 - 2033 (US$M)
